Total Payments
$3,567
2024 Payments
$278.19
Companies
18
Transactions
165
Medicare Patients
2,559
Medicare Billing
$143,172
Payment Breakdown by Category
Food & Beverage$3,534 (99.1%)
Education$32.27 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,534 | 164 | 99.1% |
| Education | $32.27 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,231 | 77 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $650.69 | 10 | $0 (2024) |
| Novo Nordisk Inc | $367.79 | 12 | $0 (2024) |
| Abbott Laboratories | $204.39 | 7 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $136.58 | 8 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $134.50 | 22 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $132.52 | 7 | $0 (2021) |
| OptiNose US, Inc. | $124.92 | 1 | $0 (2021) |
| UROVANT SCIENCES INC | $124.74 | 1 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $119.70 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $278.19 | 3 | AstraZeneca Pharmaceuticals LP ($126.22) |
| 2023 | $548.28 | 24 | Abbott Laboratories ($192.57) |
| 2022 | $1,254 | 84 | ABBVIE INC. ($546.31) |
| 2021 | $1,486 | 54 | AbbVie Inc. ($541.82) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $126.22 | General |
| Category: Respiratory | ||||||
| 05/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $119.70 | General |
| Category: Cardiovascular | ||||||
| 03/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 11/06/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: Diabetes Care | ||||||
| 09/21/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $44.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $157.50 | General |
| Category: Diabetes Care | ||||||
| 07/19/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: Diabetes Care | ||||||
| 07/14/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: Diabetes Care | ||||||
| 05/22/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: UROLOGY | ||||||
| 05/16/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: UROLOGY | ||||||
| 04/11/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: UROLOGY | ||||||
| 04/05/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: UROLOGY | ||||||
| 03/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: UROLOGY | ||||||
| 03/14/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: UROLOGY | ||||||
| 03/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Diabetes Care | ||||||
| 02/23/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: UROLOGY | ||||||
| 02/22/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: Diabetes Care | ||||||
| 02/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 02/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 688 | 974 | $175,793 | $41,284 |
| 2022 | 12 | 679 | 996 | $171,845 | $38,808 |
| 2021 | 12 | 634 | 943 | $158,965 | $36,322 |
| 2020 | 12 | 558 | 853 | $140,002 | $26,759 |
Total Patients
2,559
Total Services
3,766
Medicare Billing
$143,172
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 309 | $94,337 | $19,431 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 124 | $25,730 | $5,629 | 21.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $13,975 | $3,653 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $9,212 | $2,908 | 31.6% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 16 | 19 | $8,132 | $2,656 | 32.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 34 | $8,975 | $2,429 | 27.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 164 | 254 | $4,058 | $2,125 | 52.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 39 | $3,524 | $1,117 | 31.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 45 | 67 | $4,902 | $637.84 | 13.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $1,170 | $372.19 | 31.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 14 | 14 | $630.00 | $172.90 | 27.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 42 | 47 | $940.00 | $103.40 | 11.0% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 12 | 13 | $208.00 | $50.05 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 185 | 349 | $106,445 | $21,122 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 103 | $21,321 | $5,079 | 23.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 43 | 43 | $14,147 | $4,449 | 31.4% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 17 | 17 | $7,276 | $2,385 | 32.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 35 | 35 | $8,005 | $2,321 | 29.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 42 | $3,660 | $1,120 | 30.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 150 | 245 | $2,205 | $722.85 | 32.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 41 | 69 | $5,037 | $661.73 | 13.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 16 | 16 | $1,080 | $411.85 | 38.1% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 11 | 11 | $924.00 | $215.80 | 23.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 17 | 17 | $765.00 | $212.19 | 27.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 40 | 49 | $980.00 | $108.89 | 11.1% |
About Keri Baker, NP-C
Keri Baker, NP-C is a Family healthcare provider based in Clarksville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1659673721.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Keri Baker, NP-C has received a total of $3,567 in payments from pharmaceutical and medical device companies, with $278.19 received in 2024. These payments were reported across 165 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,534).
As a Medicare-enrolled provider, Baker has provided services to 2,559 Medicare beneficiaries, totaling 3,766 services with total Medicare billing of $143,172. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Clarksville, IN
- Active Since 11/23/2010
- Last Updated 01/14/2026
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1659673721
Products in Payments
- UBRELVY (Drug) $593.51
- QULIPTA (Drug) $431.87
- BREZTRI (Drug) $302.62
- GEMTESA (Drug) $298.52
- Ozempic (Drug) $287.61
- NURTEC ODT (Drug) $267.02
- FARXIGA (Drug) $221.85
- FREESTYLE LIBRE (Device) $204.39
- VRAYLAR (Drug) $201.29
- TRINTELLIX (Drug) $136.58
- AIRSUPRA (Drug) $126.22
- Xhance (Drug) $124.92
- ELIQUIS (Drug) $119.70
- LEQVIO (Drug) $44.18
- Aimovig (Biological) $42.05
- Rybelsus (Drug) $40.28
- Wegovy (Drug) $32.27
- STIOLTO RESPIMAT (Drug) $29.02
- STEGLATRO (Drug) $22.13
- Vascepa (Drug) $15.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Clarksville
Rhonda Hettinger, Np, NP
Family — Payments: $35,080
Family $35,080
Kayla Teives, Np-C, NP-C
Family — Payments: $8,369
Family $8,369
Danielle Conroy, Np, NP
Family — Payments: $5,696
Family $5,696
Mrs. Terry Holt, Fnp, FNP
Family — Payments: $4,648
Family $4,648
Mrs. Carrie Hinton, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $4,601
Family $4,601
Charlsie Deloach, Fnp-Cb, FNP-CB
Family — Payments: $4,589
Family $4,589